Strong Market Performance: Revvity (NYSE: RVTY) has significantly outperformed its industry and the S&P 500, with a 56.1% year-to-date gain. Robust Diagnostics Growth: The company's diagnosti...
Levi Strauss & Co. (NYSE: LEVI) is expected ...
Five Notable Stock Gainers on October 5, 2026 Fi...
Five Notable Stock Losers on October 5, 2026 Five companies from several sectors recorded double-digit declines on October 5, 2026. Sphere Entertainment fell following a Craig-Hallum downgrade, wh
Applied Digital is expected to report its fiscal first-quarter earnings with an estimated loss of $0.30 per share on $116.30 million in revenue, as investors monitor the conversion of new data center
Investment firm Needham significantly raised its price target for Vaxcyte (NASDAQ: PCVX), citing positive clinical trial data for its experimental vaccine. Vaxcyte's VAX-31 pneumococcal vaccine met a
RBC Capital maintained an "Outperform" rating for IG Group (OTC: IGGHY) despite recent challenges in its financial performance. The company cut its 2026 guidance, anticipating a 14% drop in t
Investigational drug Rina-S demonstrated a 45.9% confirmed response rate in Phase 1/2 trials for platinum-resistant ovarian cancer, with a median response duration of 12.1 months. Despite som
BNP Paribas Exane raised NVIDIA (NASDAQ: NVDA)’s price target to $345 from $285, reflecting strong demand for its AI chips. NVIDIA shares are outperforming the broader S&P 500 in 2026, thou
